FRANK KARBE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANK KARBE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANK KARBE. FRANK KARBE is Director in ADURO BIOTECH, INC. ($ADRO) and Director in Arbutus Biopharma Corp ($TKMR) and Principal Fin'l & Accounting in Myovant Sciences Ltd. ($MYOV).
Latest Insider Trading Transactions of FRANK KARBE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TKMR, ADRO, MYOV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 17.88 | 97,534 | 1,743,908 | 97,534 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 63,138 | 0 | 215,528 | 152.4 K to 215.5 K (+41.43 %) |
| Apr 08 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 18.63 | 11,080 | 206,420 | 152,390 | 163.5 K to 152.4 K (-6.78 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 181,744 | |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 181,744 | |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.40 | 750 | 16,050 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.40 | 750 | 16,050 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Feb 01 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 300 | 1,533 | 182,494 | |
| Feb 01 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.00 | 300 | 7,200 | 163,470 | 163.8 K to 163.5 K (-0.18 %) |
| Feb 01 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 300 | 1,533 | 163,770 | 163.5 K to 163.8 K (+0.18 %) |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 182,794 | |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.50 | 750 | 16,125 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Dec 30 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 11,800 | 60,298 | 183,544 | |
| Dec 30 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 30.00 | 11,800 | 354,000 | 163,470 | 175.3 K to 163.5 K (-6.73 %) |
| Dec 30 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 11,800 | 60,298 | 175,270 | 163.5 K to 175.3 K (+7.22 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 1,050 | 5,366 | 195,344 | |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.45 | 670 | 16,383 | 163,470 | 164.1 K to 163.5 K (-0.41 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 23.63 | 380 | 8,980 | 164,140 | 164.5 K to 164.1 K (-0.23 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 1,050 | 5,366 | 164,520 | 163.5 K to 164.5 K (+0.64 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 1,050 | 5,366 | 195,344 | |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.45 | 670 | 16,383 | 163,470 | 164.1 K to 163.5 K (-0.41 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 23.63 | 380 | 8,980 | 164,140 | 164.5 K to 164.1 K (-0.23 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 1,050 | 5,366 | 164,520 | 163.5 K to 164.5 K (+0.64 %) |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 1,500 | 7,665 | 196,394 | |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.00 | 1,500 | 36,000 | 163,470 | 165 K to 163.5 K (-0.91 %) |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 1,500 | 7,665 | 164,970 | 163.5 K to 165 K (+0.92 %) |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 197,894 | |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.00 | 750 | 15,000 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 199,394 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.73 | 750 | 16,298 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 21,150 | 108,077 | 200,144 | |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 3,650 | 18,652 | 221,294 | |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.01 | 21,150 | 423,275 | 163,470 | 184.6 K to 163.5 K (-11.46 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 21,150 | 108,077 | 184,620 | 163.5 K to 184.6 K (+12.94 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.04 | 3,650 | 73,146 | 163,470 | 167.1 K to 163.5 K (-2.18 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 3,650 | 18,652 | 167,120 | 163.5 K to 167.1 K (+2.23 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 700 | 3,577 | 224,944 | |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.00 | 700 | 14,000 | 163,470 | 164.2 K to 163.5 K (-0.43 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 700 | 3,577 | 164,170 | 163.5 K to 164.2 K (+0.43 %) |
| May 28 2020 | ADRO | ADURO BIOTECH, INC ... | KARBE FRANK | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 8.08 | 183,991 | 1,486,647 | 183,991 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 120,146 | 0 | 163,470 | 43.3 K to 163.5 K (+277.32 %) |
| Dec 30 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 15.55 | 19,701 | 306,351 | 43,324 | 63 K to 43.3 K (-31.26 %) |
| Dec 30 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 15.55 | 19,701 | 306,351 | 43,324 | 63 K to 43.3 K (-31.26 %) |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 7.78 | 132,270 | 1,029,061 | 132,270 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | D | 24.44 | 132,270 | 3,232,679 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 7.78 | 114,690 | 892,288 | 114,690 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | D | 21.87 | 114,690 | 2,508,270 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 7.78 | 200,000 | 1,556,000 | 200,000 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | D | 12.68 | 200,000 | 2,536,000 | 0 | |
| Aug 27 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 55,025 | 0 | 63,025 | 8 K to 63 K (+687.81 %) |
| Jun 11 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | P | 9.10 | 8,000 | 72,800 | 8,000 | 0 to 8 K |
| May 15 2019 | ADRO | ADURO BIOTECH, INC ... | KARBE FRANK | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
| Apr 19 2019 | ADRO | ADURO BIOTECH, INC ... | KARBE FRANK | Director | Option Exercise | A | 3.38 | 60,000 | 202,800 | 60,000 | |
| Apr 09 2019 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 24.44 | 132,270 | 3,232,679 | 132,270 | |
| Apr 18 2018 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 21.87 | 114,690 | 2,508,270 | 114,690 | |
| Jun 23 2017 | TKMR | Arbutus Biopharma ... | KARBE FRANK | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Jun 07 2016 | TKMR | Arbutus Biopharma ... | KARBE FRANK | Director | Option Exercise | A | 3.99 | 7,500 | 29,925 | 7,500 | |
| Aug 14 2015 | TKMR | Arbutus Biopharma ... | KARBE FRANK | Director | Option Exercise | A | 9.11 | 7,500 | 68,325 | 7,500 |
Page: 1